Caveat anicula! Beware of quiet little old ladies: Demographic features, pharmacotherapy, readmissions and survival in a 10-year cohort of patients with heart failure and preserved systolic function

Medical Journal of Australia

Volumn 192, Issue 1, 2010, Pages 9-13

  Wong, Dennis T ^a   Clark, Robyn A ^b   Dundon, Benjamin K ^a   Philpott, Andrew ^a   Molaee, Payman ^a   Shakib, Sepehr ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CARVEDILOL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; CARBAZOLE DERIVATIVE; PROPANOLAMINE DERIVATIVE;

AGED; ANEMIA; ARTICLE; CLINICAL PRACTICE; COMORBIDITY; DEMOGRAPHY; ECHOCARDIOGRAPHY; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART FAILURE WITH PRESERVED SYSTOLIC FUNCTION; HEART MUSCLE ISCHEMIA; HOSPITAL READMISSION; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; NURSING HOME; POPULATION RESEARCH; RETROSPECTIVE STUDY; SOCIAL SUPPORT; SURVIVAL; TERTIARY HEALTH CARE; AUSTRALIA; COHORT ANALYSIS; DIASTOLIC HEART FAILURE; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; LENGTH OF STAY; RISK FACTOR; SEX DIFFERENCE; STATISTICS; TIME; TREATMENT FAILURE;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; AUSTRALIA; CARBAZOLES; COHORT STUDIES; COMORBIDITY; FEMALE; HEART FAILURE, DIASTOLIC; HUMANS; LENGTH OF STAY; MALE; PATIENT READMISSION; PROPANOLAMINES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS; SOCIAL SUPPORT; STROKE VOLUME; TIME FACTORS; TREATMENT FAILURE; VENTRICULAR FUNCTION, LEFT;

EID: 77449112900     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2010.tb03393.x     Document Type: Article

References (28)

1. Hogg K, Swedberg K, McMurray J. Heart failure with preserved left ventricular systolic function: epidemiology, clinical characteristics and prognosis. J Am Coll Cardiol 2004; 43: 317-327. (Pubitemid 38167688)
2. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008; 29: 2388-2442.
3. The Heart Failure Society of America (HFSA). 2006 Comprehensive heart failure practice guidelines. J Card Fail 2006; 12: e1-e122.
4. Krum H, Jelinek MV, Stewart S, et al. Guidelines for the prevention, detection and management of people with chronic heart failure in Australia. Med J Aust 2006; 185: 549-556. (Pubitemid 44816942)
5. Auregemma GP, Zile MR, Gaasch WH. Contractile behaviour of the left ventricle in diastolic heart failure with emphasis on regional systolic function. Circulation 2006; 113: 296-304. (Pubitemid 43754388)
6. Dauterman KW, Massie BM, Gheorghiade M. Heart failure associated with preserved systolic function: a common and costly clinical entity. Am Heart J 1998; 135 (6 Pt 2 Suppl): S310-S319.
7. McMurray J, Carson P, Komajda M, et al. Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial. Eur J Heart Fail 2008; 10: 149-156.
8. Bhatia RS, Tu JV, Lee DS, et al. Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med 2006; 355: 260-269.
9. Gottdiener JS, McClelland RL, Marshall R, et al. Outcome of congestive heart failure in elderly persons: influence of left ventricular systolic function. The Cardiovascular Health Study. Ann Intern Med 2002; 137: 631-639.
10. Ho KK, Pinsky JL, Kannel WB, et al. The epidemiology of heart failure. The Framingham Study. J Am Coll Cardiol 1993; 22 (4 Suppl A): 6A-13A.
11. Jiamsripong P, Honda T, Reuss CS, et al. Three methods for evaluation of left atrial volume. Eur J Echocardiogr 2008; 9: 351-355.
12. Diller PM, Smucker DR, David B, Graham RJ. Congestive heart failure due to diastolic or systolic dysfunction. Frequency and patient characteristics in an ambulatory setting. Arch Fam Med 1999; 8: 414-420.
13. World Medical Association. World Medical Association Declaration of Helsinki. Ethical principles for medical research involving human subjects. http://www.wma.net/en/30publications/10policies/b3/index.html (accessed May 2008).
14. Broadhead WE, Kaplan BH, James SA, et al. The epidemiologic evidence for a relationship between social support and health. Am J Epidemiol 1983; 117: 521-537.
15. Moody HR. Family support for the elderly: the international experience. Ethics in an aging society. Baltimore: Oxford University Press, 1992.
16. McClellan WM, Flanders WD, Langston RD, et al. Anaemia and renal insufficiency are independent risk factors for death among patients with congestive heart failure admitted to community hospital: a population-based study. J Am Soc Nephrol 2002; 13: 1928-1936.
17. Aronow WS, Kronzon I. Effect of enalapril on congestive heart failure treated with diuretics in elderly patients with prior myocardial infarction and normal left ventricular ejection fraction. Am J Cardiol 1993; 71: 602-604.
18. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med 1992; 117: 502-510.
19. Brutsaert DL, Sys SU, Gillebert TC, et al. Diastolic failure: pathophysiology and therapeutic implications. J Am Coll Cardiol 1993; 22: 318-325.
20. Ahmed A, Rich MW, Love TE, et al. Digoxin and reduction in mortality and hospitalisation in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 2006; 27: 178-186. (Pubitemid 43069034)
21. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10 year period. Arch Intern Med 1999; 159: 29-34. (Pubitemid 29044116)
22. McDermott MM, Feinglass J, Lee PI, et al. Hospitalised congestive heart failure patients with preserved vs abnormal left ventricular systolic function: clinical characteristics and drug therapy. Am J Med 1995; 134: 728-736. (Pubitemid 26006444)
23. McDermott MM, Feinglass J, Lee PI, et al. Systolic function, readmission rates and survival among consecutively hospitalized patients with congestive heart failure. Am Heart J 1997; 134: 728-736. (Pubitemid 27465069)
24. Stewart S, MacIntyre K, Hole DA, et al. More malignant than cancer? Five year survival following first year admission for heart failure in Scotland. Eur J Heart Fail 2001; 3: 331-1322 (Pubitemid 32895839)
25. Maisel AS, Koon J, Krishnaswamy P, et al. Utility of B-natriuretic peptide as a rapid, point-ofcare test for screening patients undergoing echocardiography to determine left ventricular dysfunction. Am Heart J 2001; 141: 367-374. (Pubitemid 32200264)
26. Krishnaswamy P, Lubien E, Clopton P, et al. Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. Am J Med 2001; 111: 274-279. (Pubitemid 32885622)
27. Lubien E, DeMaria A, Krishnaswamy P, et al. Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002; 1005: 595-601. (Pubitemid 34123434)
28. Tschope C, Kasner M, Westermann D, et al. The role of NT-proBNP in the diagnostics of isolated diastolic dysfunction: correlation with echocardiographic and invasive measurements. Eur Heart J 2005; 26: 2277-2284. (Pubitemid 41541392)